12:00 AM
 | 
May 27, 2013
 |  BC Week In Review  |  Company News  |  Deals

Cizzle Biotechnology, Fujirebio deal

Cizzle and Fujirebio's Fujirebio Diagnostics Inc. will co-develop Cizzle's blood test that detects a variant of CDKN1A interacting zinc finger protein...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >